
Progestin-primed ovarian stimulation improves the outcomes of IVF/ICSI cycles in infertile women with diminished ovarian reserve
Author(s) -
Chunmei Yu,
Xiuliang Dai,
Yufeng Wang,
Tingting Gao,
Fang Cao,
Xiyang Xia,
Li Chen
Publication year - 2019
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000177
Subject(s) - miscarriage , intracytoplasmic sperm injection , medicine , in vitro fertilisation , andrology , progestin , pregnancy , pregnancy rate , embryo transfer , gynecology , stimulation , live birth , luteinizing hormone , infertility , ovarian reserve , hormone , biology , genetics
Ovarian stimulation with clomiphene (CC) or progestin has been applied for patients with diminished ovarian reserve (DOR). However, it remains unclear which treatment confers greater benefits. This study aimed to compare the outcomes of progestin-primed ovarian stimulation (PPOS) protocol vs CC-primed ovarian stimulation (CPOS) in infertile women with DOR.